Stage at | Age at diagnosis | Ratio (95% CI) | |
---|---|---|---|
diagnosis | (years) | Men | Women |
I and II | 50 | 0.69 (0.46, 0.84) | 0.63 (0.28, 0.80) |
60 | 0.48 (0.31, 0.63) | 0.45 (0.24, 0.64) | |
70 | 0.40 (0.18, 0.61) | 0.25 (0.08, 0.45) | |
80 | 0.08 (0.02, 0.26) | 0.05 (0.01, 0.27) | |
III | 50 | 0.49 (0.25, 0.69) | 0.20 (0.01, 0.54) |
60 | 0.45 (0.24, 0.64) | 0.17 (0.08, 0.29) | |
70 | 0.28 (0.14, 0.43) | 0.11 (0.04, 0.25) | |
80 | 0.07 (0.01, 0.17) | 0.06 (0.01, 0.25) | |
IV | 50 | 0.32 (0.19, 0.45) | 0.27 (0.13, 0.42) |
60 | 0.22 (0.14, 0.31) | 0.12 (0.03, 0.28) | |
70 | 0.14 (0.08, 0.22) | 0.10 (0.02, 0.19) | |
80 | 0.04 (0.01, 0.14) | 0.03 (0.01, 0.16) |
Characteristics | No. (%) | No. of deaths (%)† | Percentage of deaths |
---|---|---|---|
Total | 326 | 235 | 72.1 |
Stage at diagnosis | |||
I | 22 (6.7) | 13 (5.5) | 59.1 |
II | 60 (18.4) | 35 (14.9) | 58.3 |
III | 53 (16.3) | 37 (15.8) | 69.8 |
IV | 191 (58.6) | 150 (63.8) | 78.5 |
Age at diagnosis (years) | |||
<61 | 87 (26.7) | 52 (22.1) | 59.7 |
61–70 | 122 (37.4) | 83 (35.3) | 68.0 |
>70 | 117 (35.9) | 100 (42.6) | 85.5 |
Year of diagnosis | |||
Before 1996 | 76 (23.3) | 55 (23.4) | 72.4 |
1996–1997 | 109 (33.4) | 81 (34.5) | 74.3 |
After 1997 | 141 (43.3) | 99 (42.1) | 70.2 |
Sex | |||
Male | 224 (68.7) | 155 (65.9) | 69.2 |
Female | 102 (31.3) | 80 (34.1) | 78.4 |